{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Daratumumab",
        "type": {
          "id": "1797483e-8ce5-4e43-a082-c73686aaffc9",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "6f9dbef7-af8a-4ef5-b585-83cb7ce678d8",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Human IgG1κ monoclonal antibody that binds to CD38.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Lenalidomide",
        "type": {
          "id": "6887feb5-ccbc-4210-913b-88e5528f6039",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "5e755259-21da-49a3-9d3e-a28cedda6929",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Standard of care therapy for multiple myeloma administered in both Arm A and Arm B.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Dexamethasone",
        "type": {
          "id": "f6cefd4b-c30c-4800-8a83-3928d914a577",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "088e214a-ed65-4fb9-beca-9f6d4bed618e",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Corticosteroid administered in both Arm A and Arm B; also used as pre-dose medication.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Acetaminophen/paracetamol",
        "type": {
          "id": "91c31cf5-add7-4fd7-b008-7c972901f9e4",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "740672a3-fba6-469c-9770-56585583f433",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required pre-dose medication to prevent infusion-related reactions.",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Antihistamine",
        "type": {
          "id": "2594a537-119e-4e81-9601-e293eada2890",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "9d3bceb2-ce1c-49e3-9b0a-706cea0b51e6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required pre-dose medication (e.g., diphenhydramine) to prevent infusion-related reactions."
      },
      {
        "id": "int_6",
        "name": "Aspirin",
        "type": {
          "id": "2b46f843-96f1-44de-a40d-b21feca3eeb2",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "9649a9e7-cbaa-4ada-ae12-4322a09b33f8",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended prophylaxis for deep vein thrombosis and pulmonary embolism."
      },
      {
        "id": "int_7",
        "name": "Low molecular weight heparin",
        "type": {
          "id": "46554423-5143-4a7c-9c40-ecbda112b1a4",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "09eeccae-2922-4c6e-83ce-333990cc2d43",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended prophylaxis for venous thromboembolism in high-risk subjects."
      },
      {
        "id": "int_8",
        "name": "Clarithromycin",
        "type": {
          "id": "244cd5a5-88ac-41ee-9054-d7c9a36c7acd",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "14beef2e-8a0e-4194-b935-2a13c116c01d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited therapy due to potential anti-multiple myeloma effects."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Daratumumab IV",
        "administrableDoseForm": {
          "id": "64951863-01b5-43df-bfe6-71b9e7b74589",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "474c283c-8b65-49a8-a0be-2627b40250fc",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "97dce32d-648a-49f9-8382-349dfb501b30",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "20 mg/mL",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "id": "prod_2",
        "name": "Daratumumab SC",
        "administrableDoseForm": {
          "id": "0f61a4af-84f8-45dd-b0bc-5a3a5d3f802e",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "48a87a32-1330-4b31-8ad7-a4d22b774152",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "77d2091c-b5c6-407a-9e9b-6a0813d15702",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "1800 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "id": "prod_3",
        "name": "Lenalidomide",
        "administrableDoseForm": {
          "id": "92017288-b843-4274-b330-135f9295fcfd",
          "code": "C25158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Capsule",
          "standardCode": {
            "id": "1bd7a574-d10f-4d7d-a658-6b550e59becb",
            "code": "C25158",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Capsule",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "69ec0f92-96a8-46f7-bd8a-d8d4d55a9c9f",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "25 mg, 15 mg, 10 mg, 5 mg",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_4",
        "name": "Dexamethasone",
        "administrableDoseForm": {
          "id": "732404ac-16bc-495f-a0fe-f6d0b3c81e35",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "1f5386b8-d003-46a9-a065-569349e6426b",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "8358fcd5-d79f-48f6-a807-a933d13f70c3",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "40 mg, 20 mg",
        "substanceIds": [
          "sub_4"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Daratumumab IV Regimen",
        "instanceType": "Administration",
        "dose": "16 mg/kg",
        "doseFrequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_2",
        "name": "Daratumumab SC Regimen",
        "instanceType": "Administration",
        "dose": "1800 mg",
        "doseFrequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": {
          "code": "Subcutaneous",
          "codeSystem": "USDM",
          "decode": "Subcutaneous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_3",
        "name": "Lenalidomide Regimen",
        "instanceType": "Administration",
        "dose": "25 mg",
        "doseFrequency": "Once daily on Days 1-21 of each 28-day cycle",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_4",
        "name": "Dexamethasone Regimen",
        "instanceType": "Administration",
        "dose": "40 mg",
        "doseFrequency": "Weekly",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Daratumumab",
        "instanceType": "Substance",
        "description": "Human IgG1κ monoclonal antibody"
      },
      {
        "id": "sub_2",
        "name": "rHuPH20",
        "instanceType": "Substance",
        "description": "Recombinant human hyaluronidase PH20 (used in SC formulation)"
      },
      {
        "id": "sub_3",
        "name": "Lenalidomide",
        "instanceType": "Substance",
        "description": "Immunomodulatory imide drug (IMiD)"
      },
      {
        "id": "sub_4",
        "name": "Dexamethasone",
        "instanceType": "Substance",
        "description": "Glucocorticoid"
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Electronic device (ePRO)",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      }
    ],
    "summary": {
      "interventionCount": 8,
      "productCount": 4,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Daratumumab",
        "role": "Investigational Product",
        "description": "Human IgG1κ monoclonal antibody that binds to CD38."
      },
      {
        "name": "Lenalidomide",
        "role": "Background Therapy",
        "description": "Standard of care therapy for multiple myeloma administered in both Arm A and Arm B."
      },
      {
        "name": "Dexamethasone",
        "role": "Background Therapy",
        "description": "Corticosteroid administered in both Arm A and Arm B; also used as pre-dose medication."
      },
      {
        "name": "Acetaminophen/paracetamol",
        "role": "Concomitant Medication",
        "description": "Required pre-dose medication to prevent infusion-related reactions."
      },
      {
        "name": "Antihistamine",
        "role": "Concomitant Medication",
        "description": "Required pre-dose medication (e.g., diphenhydramine) to prevent infusion-related reactions."
      },
      {
        "name": "Aspirin",
        "role": "Concomitant Medication",
        "description": "Recommended prophylaxis for deep vein thrombosis and pulmonary embolism."
      },
      {
        "name": "Low molecular weight heparin",
        "role": "Concomitant Medication",
        "description": "Recommended prophylaxis for venous thromboembolism in high-risk subjects."
      },
      {
        "name": "Clarithromycin",
        "role": "Concomitant Medication",
        "description": "Prohibited therapy due to potential anti-multiple myeloma effects."
      }
    ],
    "products": [
      {
        "name": "Daratumumab IV",
        "doseForm": "Solution",
        "strength": "20 mg/mL",
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "name": "Daratumumab SC",
        "doseForm": "Injection",
        "strength": "1800 mg",
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "name": "Lenalidomide",
        "doseForm": "Capsule",
        "strength": "25 mg, 15 mg, 10 mg, 5 mg",
        "manufacturer": "Not specified"
      },
      {
        "name": "Dexamethasone",
        "doseForm": "Tablet",
        "strength": "40 mg, 20 mg",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Daratumumab",
        "description": "Human IgG1κ monoclonal antibody"
      },
      {
        "name": "rHuPH20",
        "description": "Recombinant human hyaluronidase PH20 (used in SC formulation)"
      },
      {
        "name": "Lenalidomide",
        "description": "Immunomodulatory imide drug (IMiD)"
      },
      {
        "name": "Dexamethasone",
        "description": "Glucocorticoid"
      }
    ],
    "administrations": [
      {
        "name": "Daratumumab IV Regimen",
        "dose": "16 mg/kg",
        "frequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Daratumumab SC Regimen",
        "dose": "1800 mg",
        "frequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": "Subcutaneous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Lenalidomide Regimen",
        "dose": "25 mg",
        "frequency": "Once daily on Days 1-21 of each 28-day cycle",
        "route": "Oral",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Dexamethasone Regimen",
        "dose": "40 mg",
        "frequency": "Weekly",
        "route": "Oral or Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "devices": [
      {
        "name": "Electronic device (ePRO)",
        "manufacturer": "Not specified",
        "purpose": "Collection of Patient Reported Outcomes"
      }
    ]
  }
}